Retraction Note: J Exp Clin Cancer Res 38, 237 (2019)
https://doi.org/10.1186/s13046-019-1239-3
The Editor-in-Chief has retracted this article. After publication, concerns were raised regarding the data presented in the article. Specifically:
-
In Fig. 4j, the western blot bands representing two different cell lines appear highly similar.
-
In Figs. 4n, 5c, 6b and 6c, the western blot backgrounds appear inconsistent.
-
In Fig. 6d, the images representing Huh7-Blank and HepG2-NC groups appear to contain overlap.
Additionally, the L02 and SMMC-7721 cell lines used in Fig. 1c have been reported to be contaminated with HeLa cells. The authors have been unable to address the above concerns and have stated that these data were obtained from a third party. Furthermore, the authors have been unable to provide evidence of the Ethics Committee approval for the animal study.
The Editor-in-Chief therefore no longer has confidence in the data presented and the conclusions of the article.
Dong-Mei Wu, Zi-Hui Zheng, Shao-Hua Fan, Zi-Feng Zhang, Yong-Jian Wang, Yuan-Lin Zheng and Jun Lu have not explicitly stated whether they agree to this retraction notice. Ying-Bo Zhang has not responded to any correspondence from the editor or publisher about this retraction.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Wu, DM., Zheng, ZH., Zhang, YB. et al. Retraction Note: Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells. J Exp Clin Cancer Res 41, 121 (2022). https://doi.org/10.1186/s13046-022-02347-9
Published:
DOI: https://doi.org/10.1186/s13046-022-02347-9